NYP MD TopLine - May 2023
Leadership Updates
Watch the Latest Edition of Inside NYP

Executive Vice President & Chief Operating Officer Dr. Brian Donley met with Senior Vice President and Chief Medical Officer Dr. Deepa Kumaraiah to discuss her role as CMO, quality and patient safety metrics, and NYP’s Leading with Quality, Safety, and Experience initiative in this 8-minute video. Watch Inside NYP.

Mental Health Awareness Month and Our Responsibility as Healthcare Leaders

For Mental Health Awareness Month, Dr. Brian Donley shared a personal note on LinkedIn regarding the importance of destigmatizing issues surrounding mental health and NYP's role as a leading provider of mental health care in the Greater New York area. Read More.

News Across Our Institutions
2022 Dalio Center for Health Justice Progress Report

The Dalio Center for Health Justice aims to understand and address the root causes of health inequities, with the goal of setting a new standard of health justice for the communities we serve. The 2022 Progress Report provides a summary of work completed as well as planned work for 2023. View Progress Report.

Dalio Center for Health Justice Now Accepting Applications for Distinguished Fellows Award

The Dalio Center is pleased to announce a call for applications for its annual Health Justice Distinguished Fellows. This award will recognize the work of our Columbia and Weill Cornell Medicine faculty partners in identifying and addressing inequities and health justice at NYP and our surrounding communities. Please submit an updated CV and 300-word summary on your commitment to health justice. The deadline for applications is June 30, 2023. Read More.

Universal Masking Update

Effective May 1, masking is no longer required in most locations of NYP, including most patient care areas. Additionally, eye protection is no longer routinely recommended in patient care areas, although it is still required as part of the droplet and enhanced droplet precautions, and as part of the standard precautions when spray, splash, or splatter of bodily fluids is anticipated. Read more.

Organizational and Leadership Changes
Joan Halpern, MS, RNC-NIC, NNP, NEA-BC, Appointed to Vice President and Chief Nursing Officer at NYP/Weill Cornell

Ms.Halpern will provide leadership and oversight to NYP-WC Department of Nursing, effective June 19. She has held progressive nursing leadership positions for the past 25 years – most recently as the CNO of NYP-LMH. Ms.Halpern has led improvements in patient satisfaction, nurse-sensitive quality indicators, and nurse engagement.

Dr. Natalya Chernichenko Named Site Chief of Otolaryngology at NYP Brooklyn Methodist Hospital

In her new role, Dr. Chernichenko will lead a team of specialists and surgeons providing comprehensive otolaryngology care, and will further develop the hospital’s Head and Neck Surgical Oncology program. She will also oversee clinical leadership across NYP-BMH ambulatory care locations and serve as the Director of Otolaryngology Patient Safety and the Assistant Professor of Clinical Otolaryngology and Vice Chair in the Department of Otolaryngology – Head and Neck Surgery at NYP-WC. Read More.

Pratik Thaker Named Vice President of Operations at NYP Hudson Valley Hospital

Mr. Thaker will provide oversight and leadership to the Operations Department at NYP-HVH. He will also manage Support Services functions, including Food and Nutrition, Environment Services, Patient Transport, Radiology, Interventional Cardiology, and the administration of select clinical services departments, such as Cardiac Catheterization Lab, Rehabilitation Services, and the Cancer Center. Read More.

Spotlight on our Physicians
A Macroscopic Approach to the Intricate Brain Patterns of Gait in the Elderly

Dr. Susmit Tripathic, together with researchers at other institutions, studied patterns of gray matter volume (GMV) in the brain associated with two domains of gait, pace, and rhythm in older adults. The discoveries may propel the development of imaging markers that could predict oncoming gait deficits and cognitive decline, and offer an opportunity for early intervention and risk reduction for cardiovascular disease in the vulnerable population. Read more.

Adding Epigenetic Drug to Standard Chemotherapy Was Effective in Pilot Study for T-cell Lymphoma 

In this study, Dr. Jia Ruan and her colleagues examined the effectiveness of the drug combination in peripheral T-cell lymphoma (PCTL) patients with the T-follicular helper phenotype (TFH), since PTCL-TFH tumors typically show DNA excessive methylation marks as well as mutations in one or more methylation-regulating genes. The results show that adding azacitidine to standard chemotherapy is safe and more effective for PTCL-TFH patients. Read More.

Columbia University Launches Center for Precision Psychiatry and Mental Health with $75 Million Grant from the Stavros Niarchos Foundation (SNF)

In a joint effort with the Department of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons and Columbia’s Zuckerman Mind-Brain Behavior Institute, Columbia University announced the establishment of the SNF Center. The Center will help drive scientific innovation and medical advancement in mental health. Among the major projects of the SNF Center is the Genomic Medicine for Mental Health Advancement initiative, being conducted in close collaboration with the New York Genome Center. Read More.

Mpox Antiviral Outcomes Are Similar Regardless of HIV Status

Researchers at Columbia University’s Vagelos College of Physicians and Surgeons and Weill Cornell Medicine conducted a study using the anti-viral drug Tecovirimat to treat HIV-positive patients with mpox. The study found that mpox patients, regardless of HIV status, were pain-free and responded to the treatment similarly to those without HIV. Read More.

LEAD Spotlight
Standardizing Recognition and Management of Sickle Cell Emergencies Necessitating Emergency Red Cell Exchanges 

Sickle cell disease (SCD) is the most common inherited blood disorder in the U.S., and complications of acute crisis in SCD can be life-threatening. Dr. Lilya Abrukin (left) and Dr. Sarah Vossoughi (right) created a disease management plan that includes pathway development, Epic integration and education. Creating a standardized approach to recognition and consultation can prevent unnecessary transfusions and blood exposures, as well as avoid missed opportunities to provide a simple transfusion or red cell exposure. Read More.

Please send your questions or comments to Chanelle Green ( who will help direct your inquiry to the appropriate department.
© 2023 NewYork-Presbyterian
Office of Communications
466 Lexington Avenue, 11th floor
New York, NY 10017

Privacy Notice | Update your preferencesunsubscribe from this list | Forward